Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Developments in endocrine therapy for breast cancer].

Akira Matsui1, Tadashi Ikeda, Hiromitsu Jinno

  • 1Keio Cancer Center, Keio University Hospital.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|July 31, 2002
PubMed
Summary

Endocrine therapy, including tamoxifen and aromatase inhibitors, is a key breast cancer treatment. Ongoing research into estrogen receptor mechanisms promises new, more effective therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic impact of progesterone receptor status in patients with breast cancer and isolated locoregional recurrence.

Breast cancer (Tokyo, Japan)·2026
Same author

Optimizing axillary surgery for patients with clinically node-negative and node-positive breast cancer.

Surgery today·2026
Same author

Minimal change disease in a patient with type 1 diabetes and Crohn's disease managed with advanced hybrid closed-loop insulin therapy during corticosteroid treatment.

Diabetology international·2026
Same author

Clinical Predictors and Long-term Outcomes of Non-benign Breast Phyllodes Tumors.

Cancer diagnosis & prognosis·2026
Same author

Pasture Intake of Whole-Day Stocked Thoroughbred Foals With Growth.

Animal science journal = Nihon chikusan Gakkaiho·2026
Same author

Synchronous Bilateral Breast Invasive Ductal Carcinoma With Osteoclast-Like Stromal Giant Cells in a 44-Year-Old Woman: A Case Report.

Cureus·2026

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Context:

  • Endocrine therapy is a cornerstone in breast cancer treatment.
  • Estrogen receptors (ERs) are crucial biomarkers for predicting response to endocrine therapy.
  • Ovariectomy and subsequent endocrine therapies have proven effective.

Purpose:

  • To review the evolution and current status of endocrine therapy for breast cancer.
  • To highlight key agents like tamoxifen, LH-RH analogues, and aromatase inhibitors.
  • To discuss future directions in endocrine breast cancer treatment.

Summary:

  • Tamoxifen, a selective estrogen receptor modulator, improves survival in breast cancer.
  • LH-RH analogues offer ovariectomy-like effects for premenopausal women, showing efficacy comparable to chemotherapy.

Related Experiment Videos

  • Aromatase inhibitors are effective for postmenopausal women, with results matching or exceeding tamoxifen.

    • Impact:

    • Established endocrine therapy as a primary breast cancer treatment modality.
    • Identified ERs as critical predictive markers for endocrine responsiveness.
    • Paved the way for novel therapeutic strategies and combination treatments.